|Number of partners||24|
|Collaterals/Dissemination items||Website, flyer, visit card, videos|
Nuclear therapy and molecular imaging are widely used at hospitals for new promising medical procedures. They can drastically improve the outcome for many medical conditions, and enables treating disseminated cancer in particular. However, its effective development has long been limited by the difficult access to radionuclides not yet commercially available. With PRISMAP – The European medical radionuclides programme, this is about to change.
The main goal of PRISMAP is to provide a sustainable source of high purity grade new radionuclides for medicine, involving from the onset upcoming major European infrastructures, to provide a single-entry point for all researchers active in this field including SMEs, global pharma, nuclear centres, hospitals and universities, using standardised access procedures.
The PRISMAP logo set
PRISMAP visual identity general guidelines
The PRISMAP production flowchart, showcasing the visual language of the project
Clyde, the project's mascot, a playful interpretation of the visual identity
|Paper||250 g/m2 glossy paper|
Cover pages of the project's flyer
Opening the flyer reveals the partners and facilities map
Left spread of the fully-opened flyer
Right spread of the fully-opened flyer
|Paper||250g/m2 glossy paper|
|Introductory videos||Number of videos||4|